Poniard Pharmaceuticals, Inc. (PARD)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jun 18, 2026, 4:00 PM EST
Poniard Pharmaceuticals Market Cap
Poniard Pharmaceuticals has a market cap or net worth of $150 as of June 18, 2026. Its market cap has decreased by -99.90% in one year.
Market Cap
150.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 11, 1988, Poniard Pharmaceuticals's market cap has decreased from 100.37M to 150.00, a decrease of -100.00%. That is a compound annual growth rate of -29.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 150.00 | 14,900.00% |
| Dec 30, 2021 | 1.00 | -100.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spencer Pharmaceutical | 271.00 |
| Sirona Biochem | 266.00 |
| Nanobac Pharmaceuticals | 250.00 |
| Kiromic BioPharma | 157.00 |
| NexImmune | 139.00 |
| Seelos Therapeutics | 136.00 |
| PsyBio Therapeutics | 133.00 |
| Marizyme | 132.00 |